Investor Relations
Financial Reports
Investor Presentations
Press Releases
2/3/2010Labopharm Receives FDA Approval For OLEPTRO(TM)
1/8/2010Labopharm settles $1 million draw down under standby equity distribution agreement
full list of press releases
> News Release Sign-Up